Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Rubicon Research Private Limited v. Kartha Pharmaceuticals Inc. et al
-
September 17, 2021
Polish Pharma Co. Gets Arbitration Bid OK'd In IP Fight
A North Carolina judge has signed off on a bid by a Polish pharmaceuticals manufacturer to force arbitration in Switzerland of a dispute over trade secrets relating to a muscle relaxant, rejecting an argument that the company had waived arbitration by seeking an injunction first.
-
August 12, 2021
IP Forecast: Activision Eyes Axing Patents Before Texas Trial
A Texas federal judge next week will hear motions by video game giant Activision Blizzard Inc. to invalidate or substantially trim a developer's patents asserted against it. Here's a look at that case — plus all the other major intellectual property matters on deck in the coming week.
-
July 06, 2021
Polish Drug Co. Says Trade Secret Fight Belongs In Arbitration
Zaklady Farmaceutyczne Polpharma SA urged a North Carolina federal judge to let it pursue a Swiss arbitration over allegedly stolen trade secrets, blasting a U.S. pharmaceutical company for arguing an "unprecedented — and nonsensical — theory" against the proceedings.